Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | TCRX | GLUE | ||
| Company | Pdl Biopharma Inc | Tscan Therapeutics Inc | Monte Rosa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.73 | 5.26 | 5.51 | ||
| High | 2.78 | 5.39 | 5.53 | ||
| Low | 2.39 | 5.16 | 5.29 | ||
| Last | 2.47 | 5.37 | 5.52 | ||
| Change | -0.23 | +0.11 | +0.03 | ||
| % Change | -8.52% | +2.09% | +0.55% | ||
| Volume | 30,270,700 | 87,500 | 120,400 | ||
| 20-Day Average Volume | 4,709,610 | 201,055 | 542,300 | ||
| Previous Close | 2.70 | 5.26 | 5.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 5.30 | 5.25 | ||
| 20-Day Raw Stochastic | 17.78% | 67.71% | 45.34% | ||
| 20-Day Relative Strength | 46.04% | 46.23% | 52.42% | ||
| Weighted Alpha | -24.80 | +36.33 | +25.46 | ||
| Today's Opinion | 64% Sell | 88% Sell | 24% Buy | ||
| Previous Opinion | 40% Sell | 100% Sell | 24% Buy | ||
| Last Month's Opinion | 56% Sell | 80% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | -0.37% since 10/11/24 | +11.97% since 10/11/24 | ||
| Low | 2.39 on 12/30/20 | 5.16 on 10/18/24 | 4.80 on 10/14/24 | ||
| High | 2.84 on 12/29/20 | 5.68 on 10/16/24 | 5.69 on 10/17/24 | ||
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | -3.07% since 09/18/24 | -7.23% since 09/18/24 | ||
| Low | 2.39 on 12/30/20 | 4.72 on 10/02/24 | 4.59 on 10/09/24 | ||
| High | 2.84 on 12/29/20 | 5.82 on 09/19/24 | 6.84 on 09/20/24 | ||
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | -22.40% since 07/18/24 | +25.74% since 07/18/24 | ||
| Low | 2.09 on 11/02/20 | 4.72 on 10/02/24 | 3.52 on 08/08/24 | ||
| High | 3.24 on 10/01/20 | 7.44 on 07/26/24 | 7.05 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | -22.40% since 04/18/24 | -6.76% since 04/18/24 | ||
| Low | 2.09 on 11/02/20 | 4.72 on 10/02/24 | 3.21 on 06/28/24 | ||
| High | 3.78 on 08/19/20 | 9.69 on 05/21/24 | 7.05 on 08/27/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 283,874 | 278,826 | ||
| Shares Outstanding, K | 114,227 | 52,863 | 50,512 | ||
| Annual Sales | 54,760,000 | 21,050,000 | 0 | ||
| Annual Net Income | -70,410,000 | -89,220,000 | -135,350,000 | ||
| Last Quarter Sales | 4,120,000 | 540,000 | 4,700,000 | ||
| Last Quarter Net Income | 4,400,000 | -31,660,000 | -30,310,000 | ||
| 60-Month Beta | 1.11 | 0.77 | 1.43 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.28 on 08/12/24 | -0.43 on 08/08/24 | ||
| Latest Earnings Date | 12/31/21 | 11/14/24 | 11/14/24 | ||
| Most Recent Dividend | 0.050 on 06/02/16 | N/A | N/A | ||
| Next Ex-Dividends Date | 09/21/20 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||